Oncology
ORSERDU – Elacestrant
¥39,105.00
Elacestrant is listed in the VetinoPharma B2B pharmaceutical product catalog under Oncology. It is commonly referenced in er-positive her2-negative breast cancer reference, including esr1 mutation contexts within professional pharmaceutical sourcing contexts. For wholesale, distribution, or sourcing inquiries, please contact the VetinoPharma team.
Get a Quote
For wholesale, distribution, or sourcing inquiries, please contact our team.


